Showing 1 - 10 of 579
The paper evaluates a capitation-financed system of mental health services delivery developed in Rochester, New York. Cost/benefit analysis of the treatment program is implemented on three years of data using program evaluation techniques. Patient outcomes are compared across randomly assigned...
Persistent link: https://www.econbiz.de/10013222225
A broad body of interdisciplinary research establishes that transgender and non-binary individuals face discrimination across many contexts, including healthcare. Simultaneously, transgender individuals face various mental health disparities, including higher rates of depression and anxiety,...
Persistent link: https://www.econbiz.de/10013223586
Physicians prescribing drugs for patients with schizophrenia and related conditions are remarkably concentrated in their choice among antipsychotic drugs. In 2007 the single antipsychotic drug prescribed by a physician accounted for 66% of all antipsychotic prescriptions written by that...
Persistent link: https://www.econbiz.de/10013115174
Using annual cross-sectional data on over 100,000 adolescents aged 12-17, we studied academic and behavioral outcomes among those who were and were not likely affected by FDA warnings regarding the safety of antidepressants. Just before the FDA warnings, adolescents with probable depression had...
Persistent link: https://www.econbiz.de/10013092388
We study the impact of cognitive behavioral therapy (CBT) for individuals selected from the general population of poor households in rural Ghana. Results from 2-3 months after a randomized intervention show strong impacts on mental and physical health, cognitive and socioemotional skills, and...
Persistent link: https://www.econbiz.de/10014357154
Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia. We extend research in this area by taking a new approach to...
Persistent link: https://www.econbiz.de/10012760589
Does drug treatment for depression with selective serotonin reuptake inhibitors (SSRIs) increase or decrease the risk of completed suicide? The question is important in part because of recent government warnings that question the safety of SSRIs, one of the most widely prescribed medications in...
Persistent link: https://www.econbiz.de/10012777650
We examine differences in the prescribing of psychiatric medications to low-income and higher-income children in the Canadian province of Ontario. The analysis takes advantage of an expansion to universal public drug coverage followed by a contraction in access, coupled with rich administrative...
Persistent link: https://www.econbiz.de/10014263897
We estimate the effect of local access to office-based mental healthcare on crime. We leverage variation in the number of mental healthcare offices within a county over the period 1999 to 2014 in a two-way fixed-effects model. We find that increases in the number of mental healthcare offices...
Persistent link: https://www.econbiz.de/10014265067
We propose new methods to model behavior and conduct welfare analysis in complex environments where some choices are unlikely to reveal preferences. We develop a mixture-of-experts model that incorporates heterogeneity in consumers' preferences and in their choice processes. We also develop a...
Persistent link: https://www.econbiz.de/10012890479